LVEF降低组

(n = 47)

LVEF正常组

(n = 100)

P值

性别(女性，n [%])

7 [0.148]

20 [0.2]

0.457

年龄(岁)

62.74 ± 9.1

60.28 ± 11.13

0.188

体重指数(kg/m²)

22.93 ± 3.16

24.44 ± 3.16

0.338

心率(次/min)

73.94 ± 11.17

70.72 ± 10.95

0.101

收缩压(mmHg)

113.64 ± 15.93

114.45 ± 16.87

0.782

舒张压(mmHg)

70.38 ± 12.76

71.49 ± 12.15

0.613

吸烟史(%)

26 [0.55]

51 [0.51]

0.626

既往病史n [%]

高血压病

20 [0.425]

30 [0.3]

0.135

糖尿病

5 [0.106]

16 [0.16]

0.388

冠心病

1 [0.02]

4 [0.04]

0.561

肌酐(umol/L)

73.5 [44, 232]

70 [41, 484]

0.961

Killip分级n [%]

I

31 [0.659]

78 [0.78]

0.121

II

13 [0.276]

19 [0.19]

0.237

III

2 [0.042]

1 [0.01]

0.194

IV

1 [0.02]

2 [0.02]

0.959

心梗部位n [%]

前壁/前间壁

34 [0.723]

49 [0.49]

0.008^aa

侧壁/高侧壁

3 [0.06]

2 [0.02]

0.173

下壁/后壁

15 [0.34]

51 [0.51]

0.054

发病至开始溶栓时间(min)

165 [25, 780]

150 [20, 990]

0.526

梗死相关动脉n [%]

左主干

1 [0.02]

0 [0.0]

0.145

前降支

35 [0.744]

53 [0.53]

0.014^a

回旋支

0 [0.0]

7 [0.07]

0.064

右冠状动脉

12 [0.255]

41 [0.41]

0.069

病变血管数n [%]

1

17 [0.361]

32 [0.32]

0.135

2

19 [0.404]

36 [0.36]

0.605

3

11 [0.234]

32 [0.32]

0.285

节段性室壁运动异常n [%]

29 [0.617]

22 [0.22]

0^aa

心血管药物n [%]

阿司匹林

47 [1.0]

100 [1.0]

1

ADP受体拮抗剂

47 [1.0]

100 [1.0]

1

他汀类

47 [1.0]

100 [1.0]

1

ACEI/ARB/ARNI抑制剂

20 [0.425]

42 [0.42]

0.95

β受体阻滞剂

32 [0.68]

63 [0.63]

0.549

呋塞米

3 [0.063]

3 [0.03]

0.335

醛固酮受体拮抗剂

3 [0.063]

5 [0.05]

0.731

钙通道阻滞剂

1 [0.02]

7 [0.07]

0.226

硝酸酯类

24 [0.51]

43 [0.43]

0.362